If you have Type 2 diabetes, ask your Kaiser endocrinologist about Mounjaroyou may have a coverage pathway that doesn't exist for weight loss
Those are the types of clues Eli Lillys CEO, David Ricks, says his company will pursue next year, testing whether its GLP-1 drug, tirzepatide (called Mounjaro for diabetes treatment, and Zepbound for weight loss), could help with addiction to alcohol, nicotine, and other things we dont think about [as being] connected to weight. In comments he made in December, Ricks said the drugs might be anti-hedonicsmeaning they counteract our hedonistic pursuit of pleasure, be it from food, alcohol, or drugs
Following a thoracotomy at the fourth intercostal gap on the left side, the LAD was ligated under a microscope
Compounding pharmacies create customized formulations tailored to individual patient needs, allowing flexibility in dosing that commercial pharmaceutical products sometimes cannot accommodate
Rapamycin Exerts Its Geroprotective Effects in the Ageing Human Immune System by Enhancing Resilience Against DNA Damage